A weekly publication by the Bureau of Epidemiology
April 27, 2001
"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.us
In this issue:
1. Changes in Reporting Resources
Changes in Reporting Resources
Don Ward, Surveillance Section Administrator
Veronica Johnson, who has been the technical resource for reporting issues for the past several years, has a new assignment in the Surveillance Section. She will be working with the surveillance databases to produce reports and data summaries that will allow for more extensive analysis of our disease and risk data. Veronica will no longer be the contact point for counties on surveillance policies. Please direct all communications (mail, e-mail and telephone) regarding reporting and/or surveillance matters to Don Ward at the Bureau of Epidemiology address. As an additional resource, beginning with this issue of the Epi-Update, we will publish questions and answers regarding general reporting and surveillance issues.
Question: Do we need to send a hard copy of the PEP form (animal bite) to Tallahassee even though we enter it in Merlin?
Answer: Yes, at this time, there is no capability in Merlin for the collection of extended data for PEP. Morbidity should be reported in Merlin, and the PEP form sent to the Bureau of Epidemiology
Question: The Bureau of Immunization collects data for perinatal hepatitis .Do the forms provided to the Bureau of Immunization serve as the morbidity report for the category "hepatitis B surface antigen positive pregnant woman?"
Answer: No. The morbidity report and extended data both must be reported in Merlin. The Bureaus of Immunization and Epidemiology are working toward using Merlin alone for these cases.
Question: Should I report morbidity for "hepatitis B surface antigen positive pregnant" for every pregnancy?
Answer: Yes, the purpose of this reporting is to initiate follow-up and prevention of disease in the infant.
2. Weekly Disease Table (Week 16)
| DISEASE |
1999 TO |
2000 TO |
3-YEAR |
2000 |
2001 TO |
2001 |
|
Animal Rabies |
49 |
41 |
53 |
161 |
70 |
9 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
0 |
0.3 |
2 |
1 |
0 |
|
Campylobacteriosis |
208 |
206 |
193.3 |
1025 |
188 |
10 |
|
Ciguatera |
0 |
0 |
0 |
14 |
0 |
0 |
|
Cryptosporidiosis |
21 |
12 |
20 |
180 |
19 |
1 |
|
Cyclosporiasis |
0 |
1 |
1 |
9 |
22 |
0 |
|
Dengue Fever |
1 |
0 |
0.7 |
5 |
1 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
2 |
2 |
2.3 |
7 |
0 |
0 |
|
Encephalitis, influenza |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
1 |
1 |
0.7 |
8 |
1 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
10 |
9 |
7.7 |
96 |
6 |
0 |
|
Escherichia Coli, other |
7 |
3 |
4 |
14 |
1 |
0 |
|
Giardiasis |
220 |
247 |
250 |
1466 |
209 |
19 |
|
H. Influenzae Cellulitis |
0 |
0 |
0.3 |
1 |
0 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
1 |
0 |
0 |
|
H. Influenzae Meningitis |
7 |
1 |
4 |
11 |
3 |
0 |
|
H. Influenzae Pneumonia |
2 |
2 |
2.3 |
8 |
11 |
3 |
|
H. Influenzae Prim.Bacteremia |
6 |
13 |
8.3 |
57 |
30 |
0 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
1 |
3 |
1.3 |
17 |
1 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
161 |
144 |
155 |
592 |
153 |
4 |
|
Hepatitis B |
82 |
97 |
89.7 |
528 |
101 |
9 |
|
Hepatitis B (+HbsAg in pregnant women) |
5 |
77 |
27.3 |
493 |
72 |
6 |
|
Hepatitis, Perinatal Hep B |
0 |
0 |
0 |
1 |
1 |
0 |
|
Hepatitis C |
9 |
4 |
4.3 |
21 |
4 |
0 |
|
Hepatitis, Non-A, Non-B |
0 |
3 |
7.7 |
6 |
1 |
0 |
|
Hepatitis, Other, including unspecified |
4 |
4 |
2.7 |
7 |
3 |
0 |
|
Lead Poisoning |
439 |
342 |
407 |
1223 |
165 |
13 |
|
Legionellosis |
7 |
14 |
11.7 |
52 |
10 |
0 |
|
Leprosy |
0 |
0 |
1 |
4 |
0 |
0 |
|
Leptospirosis |
0 |
0 |
0 |
2 |
0 |
0 |
|
Listeriosis |
5 |
8 |
4.3 |
32 |
7 |
0 |
|
Lyme Disease |
3 |
6 |
5 |
55 |
1 |
0 |
|
Malaria |
22 |
17 |
18.3 |
90 |
14 |
2 |
|
Measles |
1 |
0 |
0.7 |
2 |
0 |
0 |
|
Meningitis, Group B Strep |
5 |
5 |
5 |
21 |
4 |
0 |
|
Meningitis, List Monocytogenes |
2 |
1 |
1.7 |
7 |
0 |
0 |
|
Meningitis, Meningococcal |
14 |
10 |
12.7 |
41 |
28 |
0 |
|
Meningitis, other |
15 |
25 |
18.7 |
110 |
18 |
4 |
|
Meningitis, Strep Pneumoniae |
44 |
41 |
41.3 |
110 |
24 |
0 |
|
Meningococcemia, disseminated |
21 |
23 |
25.3 |
81 |
18 |
1 |
|
Mercury Poisoning |
1 |
3 |
1.3 |
11 |
0 |
0 |
|
Mumps |
1 |
0 |
3 |
4 |
0 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
7 |
8 |
8.7 |
48 |
4 |
0 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0 |
3 |
0 |
0 |
|
Q Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
1 |
0 |
0.7 |
1 |
1 |
0 |
|
Rubella |
0 |
1 |
0.7 |
2 |
0 |
0 |
|
Rubella, Congenital |
0 |
0 |
0 |
1 |
0 |
0 |
|
Salmonellosis |
423 |
371 |
392.7 |
2756 |
405 |
26 |
|
Shigellosis |
370 |
348 |
362.3 |
1295 |
164 |
13 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
15 |
43 |
24.7 |
150 |
54 |
8 |
|
Streptococcus Pneumoniae, Invasive |
177 |
340 |
229.7 |
1149 |
364 |
21 |
|
Tetanus |
1 |
0 |
0.7 |
1 |
1 |
0 |
|
Toxoplasmosis |
4 |
2 |
3.3 |
12 |
3 |
3 |
|
Trichinosis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
|
Typhoid Fever |
17 |
1 |
8.3 |
12 |
2 |
0 |
|
Vibrio Alginolyticus |
2 |
2 |
1.7 |
15 |
0 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
3 |
1 |
1.7 |
4 |
0 |
0 |
|
Vibrio Fluvialis |
1 |
0 |
0.3 |
2 |
0 |
0 |
|
Vibrio Hollisae |
3 |
3 |
2.7 |
3 |
0 |
0 |
|
Vibrio Mimicus |
1 |
1 |
0.7 |
2 |
0 |
0 |
|
Vibrio, other |
1 |
0 |
0.3 |
2 |
0 |
0 |
|
Vibrio Parahaemolyticus |
2 |
1 |
1.3 |
16 |
0 |
0 |
|
Vibrio Vulnificus |
2 |
0 |
1 |
13 |
0 |
0 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |